Results 11 to 20 of about 343 (127)

Valuation survey for SF-6Dv2 in Japan based on the international protocol [PDF]

open access: yesQual Life Res
Purpose: The SF-6D Classification System was recently updated (SF-6Dv2). We performed a valuation survey to construct a value set for the SF-6Dv2 in Japan. Methods: An online discrete choice experiment (DCE) with duration was used to estimate a value
Bjorner, J.   +8 more
core   +7 more sources

Creating an SF-6Dv2 social value set for New Zealand [PDF]

open access: yesSocial Science and Medicine
The SF-6D health descriptive system and its second version published in 2020, the SF-6Dv2, is used worldwide for valuing health-related quality of life (HRQoL) for economic evaluation and measuring patient-reported health outcomes.
Trudy Sullivan   +2 more
exaly   +4 more sources

Health utility scores of six common cancers in China measured by SF-6Dv2 [PDF]

open access: yesHealth and Quality of Life Outcomes
Purpose Given the recent update of SF-6Dv2, detailed data on utility scores for cancer patients by cancer type remain scarce in China and other regions, which limits the precision of cost-utility analyses (CUA) in cancer interventions.
Yuchun Tao   +7 more
doaj   +4 more sources

Valuing SF-6Dv2 Using a Discrete Choice Experiment in a General Population in Quebec, Canada [PDF]

open access: yesInternational Journal of Health Policy and Management
Background  An updated version of the Short-Form 6-Dimension (SF-6D) Classification System has been developed. This new version (SF-6Dv2) with improved consistency and dimension descriptors is now requiring the development of new utility value sets.
Hosein Ameri, Thomas G. Poder
doaj   +4 more sources

Mapping the ADDQoL to the EQ-5D-5L and SF-6Dv2 among Chinese patients with type 2 diabetes mellitus [PDF]

open access: yesHealth and Quality of Life Outcomes
Objective The Audit of Diabetes-Dependent Quality of Life (ADDQoL) is a widely used instrument for assessing quality of life in Type 2 Diabetes Mellitus (T2DM). However, it does not directly yield health utility values essential for economic evaluations.
Haoran Fang   +5 more
doaj   +4 more sources

A Comparison of the SF-6Dv2 and SF-6D UK Utility Values in a Mixed Patient and Healthy Population [PDF]

open access: yesPharmacoeconomics, 2021
This paper describes the first evaluation of the construct validity and performance of the newly developed preference-based measure of health, the SF-6D version 2 (SF-6Dv2).Utilising data from the Multi-Instrument Comparison (MIC) project (n = 7932), we explored the descriptive differences in utility values between the SF-6Dv2 and the SF-6D and ...
Emily McDool   +2 more
exaly   +7 more sources

Valuation of SF-6Dv2 health states in China using time trade-off and discrete-choice experiment with a duration dimension [PDF]

open access: yesPharmacoeconomics, 2020
Objectives Our objective was to generate a value set for the SF-6Dv2 using time trade-off (TTO) and a discrete-choice experiment with a duration dimension (DCETTO) in China.
Bai, G.   +11 more
core   +3 more sources

Assessment of health-related quality of life of patients with gout and hyperuricemia in the Tianjin area according to the SF-6Dv2 scale [PDF]

open access: yesFrontiers in Public Health
BackgroundThe number of patients with hyperuricemia and gout is constantly rising and the conditions are seriously affecting their quality of life. Thus, it is of great importance to identify a assessment scale to assess the quality of life suitable for ...
Xiaohui Zheng   +4 more
doaj   +2 more sources

Impact of COVID-19 pandemic on the health-related quality of life of frontline workers: the case of seven low-income Eastern African countries [PDF]

open access: yesHealth and Quality of Life Outcomes, 2023
Purpose This study aimed to explore the potential impact of the COVID-19 pandemic on the health-related quality of life (HRQoL) of humanitarian and healthcare workers and its related factors in seven Eastern African countries (EAC).
Alexis Nizigiyimana   +2 more
doaj   +2 more sources

Minimal clinically important difference of EQ-5D-5L, SF-6Dv2, and QLU-C10D in hematologic malignancy patients in China [PDF]

open access: yesHealth and Quality of Life Outcomes
Background To assess the minimum clinically important difference (MCID) of the EuroQol five-dimensional five-level (EQ-5D-5L), Short Form Six-Dimensional version 2 (SF-6Dv2), and Quality of Life Utility-Core 10 Dimensions (QLU-C10D) in Chinese patients ...
Fangyu Li   +6 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy